Chlorine Dioxide Injection for Cancer Tumor Elimination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments are ineffective in targeting and eliminating cancerous tumors, particularly in cases of metastatic and recurrent cancers, due to the limitations of existing therapies in addressing the unique metabolic pathways and microenvironment of cancer cells.
Innovation Solution
The use of chlorine dioxide compositions, injected directly into cancerous tumors, which oxidize polyamines and other key molecules essential for cancer cell growth, disrupting tumor metabolism and proliferation while minimizing harm to normal cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional cancer therapies are used, then general cancer treatment is provided, but they are ineffective in targeting and eliminating cancerous tumors particularly in metastatic and recurrent cases
Solution Approach 1:
The patent applies local quality by delivering chlorine dioxide compositions directly into the tumor tissue through injection, creating a high concentration of the oxidizing agent precisely where cancer cells are located. This localized delivery allows the treatment to specifically target the unique metabolic pathways and microenvironment of cancer cells without affecting the entire body, thereby improving effectiveness for metastatic and recurrent cancers while maintaining selectivity.
Solution Approach 2:
The patent employs chlorine dioxide, a strong oxidizing agent, to accelerate the oxidation of polyamines and other key molecules essential for cancer cell growth. This accelerated oxidation disrupts tumor metabolism and proliferation by rapidly depleting polyamines that cancer cells rely on for survival, particularly in metastatic and recurrent cases where conventional therapies have failed.
2Reliability
If strong oxidizing agents are used to eliminate cancer cells, then tumor elimination is achieved, but harm to normal cells may occur
Solution Approach 1:
The patent applies segmentation by dividing the treatment into localized injections delivered directly into the tumor tissue, rather than systemic administration. This segmentation confines the strong oxidizing agent's action to the tumor boundaries, allowing effective tumor elimination while minimizing exposure and potential damage to surrounding normal tissues.
Solution Approach 2:
The patent uses the tumor tissue itself as an intermediary that confines and directs the action of chlorine dioxide. By injecting the oxidizing agent directly into the tumor, the tumor tissue acts as a containment boundary that prevents the agent from freely diffusing into surrounding healthy tissues, thereby protecting normal cells while maintaining effective tumor elimination.
3Reliability
If polyamine synthesis is inhibited using DFMO, then tumor growth is reduced in animal models, but the approach has proven generally ineffective in clinical trials
Solution Approach 1:
The patent replaces the enzymatic inhibition mechanism of DFMO (which blocks polyamine synthesis enzymes) with a direct chemical oxidation mechanism using chlorine dioxide. This substitution of mechanism allows for more effective polyamine depletion because chlorine dioxide directly oxidizes existing polyamines and their precursors, bypassing the limitations of enzymatic inhibition that proved ineffective in clinical trials.
Solution Approach 2:
The patent changes the fundamental parameter of polyamine depletion from enzymatic blockade (DFMO mechanism) to direct chemical oxidation (chlorine dioxide mechanism). This parameter change transforms the treatment from a synthetic inhibition approach to an oxidative degradation approach, achieving more effective polyamine depletion in both animal models and potential clinical applications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively eliminates cancerous tumors by inducing apoptosis and necrosis in cancer cells, leading to complete remission and preventing recurrence, with minimal adverse effects on surrounding tissues and no immune system dependency.
Implementation Method 1
The use of chlorine dioxide compositions, injected directly into cancerous tumors, which oxidize polyamines and other key molecules essential for cancer cell growth
Implementation Method 2
This approach effectively eliminates cancerous tumors by inducing apoptosis and necrosis in cancer cells
Data Source
AI summary
The present invention relates to the use of chlorine dioxide compositions for treating cancerous tumors. The present invention relates to compositions and methods for treating cancerous tumors, including naïve, metastatic and recurrent cancers. The compositions comprise chlorine dioxide in an effective amount, which is injected into the cancerous tumor at least once, and often at least several times over the course of treatment. The chlorine dioxide compositions are injected directly into the cancerous tumor and the resulting tumor is effectively eliminated from the patient or subject over a period of one to several days to a few weeks, often after a single injection, or multiple injections at one session into the tumor. Often, an initial injection or multiple injections at one session are sufficient to dissolve the cancerous tumor. Often the cancer is eliminated (as evidenced by no remission) in a period of no more than several days to about two-three months and does not recur.